Deoxyribonucleic Acid (DNA) and Genomic Profiling Kits Market Report 2026

The deoxyribonucleic acid (DNA) and genomic profiling kits market size has grown rapidly in recent years. It will grow from $1.28 billion in 2025 to $1.41 billion in 2026 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to growing demand for genetic disorder screening, increasing adoption of forensic DNA profiling technologies, rising prevalence of cancer diagnostics and precision medicine, expansion of genomic research initiatives globally, technological advancements in PCR and sequencing systems.

The deoxyribonucleic acid (DNA) and genomic profiling kits market size is expected to see rapid growth in the next few years. It will grow to $2.09 billion by 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing investment in personalized medicine development, rising demand for high throughput genomic testing solutions, expanding applications of pharmacogenomics testing, growing integration of bioinformatics and cloud-based genomic analysis, increasing use of genomic profiling in infectious disease surveillance. Major trends in the forecast period include increasing adoption of rapid DNA extraction kits, rising demand for next-generation sequencing library preparation kits, growth in multiplex PCR-based genomic profiling assays, expanding use of mutation detection kits in clinical diagnostics, increasing preference for user-friendly single sample testing kits.

The rising demand for precision and personalized medicine applications is expected to propel the growth of the DNA and genomic profiling kits market going forward. Precision and personalized medicine applications refer to healthcare approaches that utilize individual genetic, environmental, and lifestyle information to guide disease prevention, diagnosis, and treatment strategies. The increasing demand for these applications is driven by the growing burden of cancer and other genetically complex diseases that require targeted therapeutic approaches. The DNA and genomic profiling kits market is supporting this demand by enabling the identification of genetic mutations and biomarkers that assist in precision oncology and individualized treatment decisions. For instance, in January 2024, according to the National Cancer Institute, a US-based government research organization, 2,001,140 new cancer cases were projected in 2024 compared to 1,958,310 cases in 2023, along with 611,720 projected deaths, highlighting an increasing need for genomics-based precision medicine approaches. Therefore, the rising demand for precision and personalized medicine applications is propelling the growth of the DNA and genomic profiling kits market.

Leading companies operating in the DNA and genomic profiling kits market are focusing on next-generation sequencing-based kit innovations, such as integrated library preparation solutions, to increase throughput and reduce per-sample sequencing costs. Integrated library preparation solutions refer to advanced reagent systems that combine DNA fragmentation, adapter ligation, and amplification into a streamlined workflow to reduce processing time, optimize reagent usage, and improve consistency in sequencing preparation. For example, in March 2023, Illumina Inc., a US-based biotechnology company, launched Illumina Complete Long Read Prep, Human. The solution enables both long-read and short-read sequencing on the same platform, which improves workflow efficiency. It also reduces DNA input requirements and supports high accuracy sequencing output, which enhances scalability and lowers overall cost per sample in genomic studies.

In January 2023, QIAGEN, a Germany-based healthcare technology company, acquired Verogen for $150 million. Through this acquisition, QIAGEN seeks to expand its leadership in DNA and genomic profiling by strengthening its next-generation sequencing (NGS)-based forensic testing portfolio and enhancing capabilities in human identification and investigative genomics. Verogen is a US-based healthcare technology company specializing in NGS-based DNA analysis solutions, including genomic profiling kits and workflows used in forensic and human identification applications.

Major companies operating in the deoxyribonucleic acid (dna) and genomic profiling kits market are Thermo Fisher Scientific, Agilent Technologies, Illumina Inc., Bio‑Rad Laboratories Inc., QIAGEN NV, 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Twist Bioscience Corporation, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macherey-Nagel GmbH & Co. KG, New England Biolabs, OriGene Technologies Inc., Element Biosciences Inc., BGI Tech Solutions Co. Ltd., Omega Bio-tek Inc., Zymo Research Corporation, Bioneer Corporation, ArcherDX Inc., Solis BioDyne, Verogen Inc., Norgen Biotek Corp., iNtRON Biotechnology Inc., Biotium Inc., NimaGen B. V., EpigenDx Inc., GeneAll Biotechnology Co. Ltd., Paragon Genomics Inc.

North America was the largest region in the DNA and genomic profiling kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (DNA) and genomic profiling kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the deoxyribonucleic acid (DNA) and genomic profiling kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The DNA and genomic profiling kits market consists of sales of DNA extraction kits, genomic DNA isolation kits, polymerase chain reaction kits, quantitative polymerase chain reaction kits, next-generation sequencing library preparation kits, genotyping kits, DNA amplification reagents, DNA quantification kits, microarray kits, and forensic DNA profiling kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.